Hedera Dx
A diagnostics platform that makes liquid biopsies a reality in cancer care
Hedera Dx is a business in health care, oncology based in Europe, Middle East, and Africa (EMEA), founded in 2021.
The company sits in the health care, oncology segment, where it competes on its core product or service.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
The company is listed at the Seed stage of development.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $14M.
| Sector | Health Care, Oncology |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $14,000,000 |
Website: www.hederadx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account